Ganesh V. Kaundinya
2016
In 2016, Ganesh V. Kaundinya earned a total compensation of $1.7M as Chief Scientific Officer and Senior Vice President, Research at Momenta Pharmaceuticals, a 11% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $201,833 |
|---|---|
| Option Awards | $221,345 |
| Salary | $433,350 |
| Stock Awards | $791,487 |
| Other | $13,091 |
| Total | $1,661,106 |
Kaundinya received $791.5K in stock awards, accounting for 48% of the total pay in 2016.
Kaundinya also received $201.8K in non-equity incentive plan, $221.3K in option awards, $433.4K in salary and $13.1K in other compensation.
Rankings
In 2016, Ganesh V. Kaundinya's compensation ranked 5,763rd out of 14,075 executives tracked by ExecPay. In other words, Kaundinya earned more than 59.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,763 out of 14,075 | 59th |
Division Manufacturing | 2,089 out of 5,486 | 62nd |
Major group Chemicals And Allied Products | 678 out of 1,900 | 64th |
Industry group Drugs | 507 out of 1,543 | 67th |
Industry Biological Products, Except Diagnostic Substances | 90 out of 287 | 69th |
Source: SEC filing on April 27, 2017.
Kaundinya's colleagues
We found five more compensation records of executives who worked with Ganesh V. Kaundinya at Momenta Pharmaceuticals in 2016.
2016
Craig Wheeler
Momenta Pharmaceuticals
Chief Executive Officer
2016
Scott Storer
Momenta Pharmaceuticals
Chief Financial Officer
2016
Bruce Leicher
Momenta Pharmaceuticals
General Counsel
2016
Matthew Ottmer
Momenta Pharmaceuticals
Chief Operating Officer
2016
Richard Shea
Momenta Pharmaceuticals